New algorithm aims to predict breast cancer spread
NCT ID NCT07372261
First seen Feb 01, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study is testing a new tool called PORTENT that may help predict if early-stage breast cancer will spread to other parts of the body. Researchers will look at two genetic markers and other health information from 1000 people with stage 1-3 breast cancer. The goal is to see how accurately the tool can estimate the risk of cancer spreading within 5 to 10 years after diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Casa Sollievo della Sofferenza IRCCS
San Giovanni Rotondo, FG, 71013, Italy
Conditions
Explore the condition pages connected to this study.